1063537--3/17/2008--NUTRACEA

related topics

{stock, price, share}

{customer, product, revenue}

{control, financial, internal}

{product, candidate, development}

{operation, international, foreign}

{personnel, key, retain}

{cost, regulation, environmental}

{acquisition, growth, future}

{property, intellectual, protect}

{regulation, change, law}

{interest, director, officer}

{regulation, government, change}

{cost, operation, labor}

Risks Related to Our Business We have a limited operating history and have generated losses in each quarter of 2007, except the second, and in each quarter before 2006. There are significant market risks associated with our business. We depend on a limited number of customers. The inability of our significant customers to meet their obligations to us may adversely affect our financial results. The inability of our significant customers to meet their obligations to us may adversely affect our financial results. We rely upon a limited number of product offerings. We are dependent upon our marketing efforts. We rely upon an adequate supply of raw rice bran. We face risks in our wheat bran stabilization efforts. We intend to pursue significant foreign operations and there are inherent risks in operating abroad. Our products could fail to meet applicable regulations which could have a material adverse affect on our financial performance. Our success depends in part on our ability to obtain patents, licenses and other intellectual property rights for our products and technology. We have identified material weaknesses in our internal control over financial reporting, which could impact negatively our ability to report our results of operations and financial condition accurately and in a timely manner. We have identified material weaknesses in our internal control over financial reporting, which could impact negatively our ability to report our results of operations and financial condition accurately and in a timely manner. We are dependent on key employees and consultants. We have not yet achieved positive cash flow Our products may require clinical trials to establish efficacy and safety. Risks Related to Our Stock Our Stock Price is Volatile. We have significant equity overhang which could adversely affect the market price of our common stock and impair our ability to raise additional capital through the sale of equity securities. Sales of Our Stock Pursuant to Registration Statements May Hurt Our Stock Price The Exercise of Outstanding Options and Warrants May Dilute Current Shareholders We may need to raise funds through debt or equity financings in the future, which would dilute the ownership of our existing shareholders and possibly subordinate certain of their rights to the rights of new investors. The authorization of our preferred stock may have an adverse effect on the rights of holders of our common stock. We may engage in future acquisitions that dilute our shareholders and cause us to incur debt or assume contingent liabilities. Compliance with corporate governance and public disclosure regulations may result in additional expenses. Our officers and directors have limited liability and have indemnification rights

Full 10-K form ▸